Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer

Autor: Smit, E.F. *, Socinski, M.A., Mullaney, B.P., Myrand, S.P., Scagliotti, G.V., Lorigan, P., Reck, M., Ciuleanu, T., von Pawel, J., Karaseva, N.A., Szczesna, A., Ohannesian, D., Powell, E., Hozak, R.R., Hong, S., Guba, S.C., Thatcher, N.
Zdroj: In Annals of Oncology July 2012 23(7):1723-1729
Databáze: ScienceDirect